| Literature DB >> 27227125 |
L Meghan Mahoney1, Tang Tang2, Kai Ji3, Jessica Ulrich-Schad4.
Abstract
BACKGROUND: New media changes the dissemination of public health information and misinformation. During a guest appearance on the Today Show, US Representative Michele Bachmann claimed that human papillomavirus (HPV) vaccines could cause "mental retardation".Entities:
Keywords: HPV vaccination; health communication; infodemiology; infoveillance; new media; public health dissemination; social media
Year: 2015 PMID: 27227125 PMCID: PMC4869234 DOI: 10.2196/publichealth.3310
Source DB: PubMed Journal: JMIR Public Health Surveill ISSN: 2369-2960
Figure 1Google News criteria.
Figure 2Google News sample articles.
Figure 3Topsy search criteria and sample articles.
Article tones used by Twitter and Google News HPV vaccination articles.
| Tones | Twitter (n=100) | Google News (n=100) | ||
| n | % | n | % | |
| Positive | 54 | 54.0 | 34 | 34.0 |
| Neutral | 29 | 29.0 | 36 | 36.0 |
| Negative | 17 | 17.0 | 30 | 30.0 |
Topics covered by Twitter and Google News HPV vaccination articles.
| Topics | Twitter (n=100) | Google News (n=100) | χ2 | df |
| ||
| Freq. | % | Freq. | % |
|
|
| |
| Protection against diseases | 75 | 75.0 | 89 | 89.0 | 6.640b | 1 | .01 |
| Side effects | 66 | 66.0 | 52 | 52.0 | 4.051a | 1 | .04 |
| Vaccine eligibility for females | 66 | 66.0 | 85 | 85.0 | 9.758b | 1 | .002 |
| Duration | 48 | 48.0 | 41 | 41.0 | 0.992 | 1 | .32 |
| Politics | 46 | 46.0 | 27 | 27.0 | 7.788a | 1 | .005 |
| Dosing | 39 | 39.0 | 33 | 33.0 | 0.781 | 1 | .38 |
| Vaccine efficacy | 39 | 39.0 | 53 | 53.0 | 3.945b | 1 | .047 |
| Vaccine cost | 33 | 33.0 | 29 | 29.0 | 0.374 | 1 | .54 |
| Vaccine eligibility for males | 31 | 31.0 | 27 | 27.0 | 0.389 | 1 | .53 |
aCovered more frequently by the Twitter articles (P<.05).
bCovered more frequently by the Google News articles (P<.05).
Types of sources referenced by Twitter and Google News HPV vaccination articles.
| Reference sources | Twitter (n=100) | Google News (n=100) | χ2 | df |
| ||
| Freq. | % | Freq. | % |
|
|
| |
| CDC | 52 | 52.0 | 41 | 41.0 | 2.432 | 1 | .12 |
| Medical doctors | 49 | 49.0 | 32 | 32.0 | 5.996a | 1 | .01 |
| Political/Government officials | 46 | 46.0 | 32 | 32.0 | 4.119a | 1 | .04 |
| Research community | 37 | 37.0 | 53 | 53.0 | 5.172b | 1 | .02 |
| Personal accounts | 31 | 31.0 | 8 | 8.0 | 16.860a | 1 | <.001 |
| Cancer organizations | 28 | 28.0 | 27 | 27.0 | 0.025 | 1 | .87 |
| Vaccine manufacturer | 8 | 8.0 | 10 | 10.0 | 0.244 | 1 | .62 |
| Other | 4 | 4.0 | 5 | 5.0 | 0.116 | 1 | .73 |
aUsed more frequently by the Twitter articles (P<.05).
bUsed more frequently by the Google News articles (P<.05).
Article sources used by the Twitter and Google News HPV vaccination articles.
| Information sources | Twitter (n=100) | Google News (n=100) | ||
| Freq. | % | Freq. | % | |
| Newspapers/Magazines | 33 | 33.0 | 55 | 55.0 |
| User-generated content | 28 | 28.0 | 1 | 1.0 |
| Health organization websites | 19 | 19.0 | 15 | 15.0 |
| Scientific journals | 7 | 7.0 | 11 | 11.0 |
| TV | 6 | 6.0 | 10 | 10.0 |
| Government websites | 4 | 4.0 | 0 | 0.0 |
| Other sources | 2 | 2.0 | 4 | 4.0 |
| Portal sites | 1 | 1.0 | 2 | 2.0 |
| Radio | 0 | 0.0 | 2 | 2.0 |
Interactive features used by Twitter and Google News HPV vaccination articles.
| Interactivity | Twitter (n=100) | Google News (n=100) | χ2 | df |
| ||
| Freq. | % | Freq. | % | ||||
| Comments | 89 | 89.0 | 65 | 65.0 | 16.262a | 1 | <.001 |
| Share | 88 | 88.0 | 92 | 92.0 | 0.889 | 1 | .35 |
| Hyperlinks | 77 | 77.0 | 90 | 90.0 | 6.133b | 1 | .01 |
| Search functions | 67 | 67.0 | 92 | 92.0 | 19.175b | 1 | <.001 |
aUsed more frequently by the Twitter articles (P<.05).
bUsed more frequently by the Google News articles (P<.05).
Topics covered by the HPV vaccination articles before and after Bachmann’s comment.
| Topics | Before (n=75) | After (n=125) | χ2 | df |
| ||
| Freq. | % | Freq. | % | ||||
| Protection against diseases | 67 | 89.3 | 97 | 77.6 | 4.372a | 1 | .04 |
| Vaccine eligibility for females | 63 | 84.0 | 88 | 70.4 | 4.687a | 1 | .03 |
| Side effects | 44 | 58.7 | 74 | 59.2 | 0.006 | 1 | .94 |
| Duration | 43 | 57.3 | 46 | 36.8 | 8.002a | 1 | .005 |
| Dosing | 39 | 52.0 | 33 | 26.4 | 13.333a | 1 | <.001 |
| Vaccine efficacy | 37 | 49.3 | 55 | 44.0 | 0.537 | 1 | .46 |
| Vaccine cost | 21 | 28.0 | 41 | 32.8 | 0.505 | 1 | .48 |
| Politics | 19 | 25.3 | 54 | 43.2 | 6.456b | 1 | .01 |
| Vaccine eligibility for males | 14 | 18.7 | 44 | 35.2 | 6.223b | 1 | .01 |
aCovered more often by the articles published before the Bachmann’s comment (P<.05).
bCovered more often by the articles published after Bachmann’s comment (P<.05).